Volume 3, Issue 4
• EDDE Journal
• Library of Congress Survey (username: glins; password: survey)
• SciTech Nominees for 2010-2011 Officer and Council Member Elections
Personal vs. Professional: Handling Employee Participation in Online Communities
Cyber on the Hill: Congressional Cybersecurity Oversight, Legislation & Initiatives for 2010
First Annual Electronic Discovery and Digital Evidence
Patent Licensing for Standards How the Deal Is Done
Prescriptions for Criminal Justice Forensics
Navigating the US Biosimilar Pathway
Flying High with Technology: A Review of Legal, Privacy, and International Issues Behind Aviation Security Tecnology
The SciTech e-Merging News is published quarterly as a Section member benefit. Click here to join the Section. The material published reflects the views of the authors and has not been approved by the Section of Science & Technology Law, the House of Delegates or the Board of Governors of the ABA. © 2010 American Bar Association. All rights reserved.
A Message from your Editor:
Greetings, dear readers! Below please find the latest issue of the BioBlurb. As always I encourage attorneys, law students, and industry professionals to submit biotech-related stories of interest to my e-mail address. In this issue, find out why the FDA chided a major drug maker, the US Supreme Court is bracing for case load increase, and venture capitalists continue to show interest in Biotech sector!
BIOTECH BREAKTHROUGHS, NEW RESEARCH DIRECTIONS & APPLICATIONS IN CLINICAL MEDICINE:
Gene Variant Linked to Thinking Skills in Elderly. A gene variant that may help protect memory and thinking skills in elderly people has been identified by U.S. researchers. Discovery may lead to new treatments for age-related memory loss, according to Health Day News (April 21, 2010).
Hormone Sensitivity of Breast Stem Cells Presents Drug Target . Researchers at the Walter and Eliza Hall Institute (Australia) have discovered that breast stem cells are exquisitely sensitive to the female hormones estrogen and progesterone, a finding that opens the way for the development of new preventions and treatments for breast cancer, according to Science Daily (April 12, 2010).
BIOTECH INDUSTRY NEWS:
LEGISLATIVE, POLICY & REGULATORY DEVELOPMENTS:
U.S. Reforms to Hurt Non-Profit Hospitals . The healthcare overhaul will ultimately hurt the credit profiles of not-for-profit hospitals, despite some positive effects, according to Reuters (April 16, 2010).
Cancer Research by U.S. Disorganized, Underfunded, Study Says . An analysis by the Institute of Medicine shows that 40% of Phase III clinical trials conducted by the Clinical Trials Cooperative Group Program, a unit of the National Cancer Institute, end up being terminated because of inefficiency and lack of funding, according to Bloomberg (April 15, 2010).
Resistance to Health Care Bill Strong . Associated Press-GfK poll finds that the number of Americans opposed to the health reform law increased after it was enacted, according to The Washington Post (April 15, 2010).
PATENT, IP & OTHER LEGAL ISSUES:
More Harm Than Good? Patenting Genes is Bad for Diagnosis . Economic rationale for single gene patenting is clear, but latest research suggests that exclusive licensing of gene-based diagnostic tests may deprive many patients of the benefits of genetic discoveries, according to The Economist (April 15, 2010).
Genetics in Medicine April 2010 Supplement:
Your e-mail address will only be used within the ABA and its entities. We do not sell or rent e-mail addresses to anyone outside the ABA.
American Bar Association | 321 N Clark | Chicago, IL 60610 | 1-800-285-2221